Radium and other alpha emitters in prostate cancer
Sign Up to like & getrecommendations! Published in 2018 at "Translational Andrology and Urology"
DOI: 10.21037/tau.2018.02.07
Abstract: 223Radium (223Ra) is the first alpha-emitting therapy proven effective in human cancer. Prospective randomized trials indicate that 223Ra, which concentrates after intravenous injection in areas of osteoblastic metastatic disease, can prolong survival in bone-dominant castrate… read more here.
Keywords: radium alpha; prostate cancer; emitters prostate; cancer ... See more keywords